findmyKOL
Clinical trialNCT00216203CompletedPhase 1/PHASE2Interventional

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer

SponsorNasser Hanna, M.D.Enrollment36Non-Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Medical & Surgical Specialists, Llc

    Galesburg, Illinois, United States

  • Cancer Care Center of Southern Indiana

    Bloomington, Indiana, United States

  • Elkhart Clinic

    Elkhart, Indiana, United States

  • Fort Wayne Oncology & Hematology, Inc

    Fort Wayne, Indiana, United States

  • Center for Cancer Care at Goshen Health System

    Goshen, Indiana, United States

  • Indiana University Cancer Center

    Indianapolis, Indiana, United States

  • Medical Consultants, P.C.

    Muncie, Indiana, United States

  • Northern Indiana Cancer Research Consortium

    South Bend, Indiana, United States

  • Greenebaum Cancer Center

    Baltimore, Maryland, United States

  • Oncology Hematology Care, Inc.

    Cincinnati, Ohio, United States

  • Texas Oncology Cancer Center

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2005
Primary completion
31 Dec 2008
Completion
31 Dec 2008
Last update posted
29 Sept 2016
Registered enrollment
36
Registry id
NCT00216203

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.